Age-related macular degeneration (AMD) is the most common cause of blindness in individuals over age 55 in developed nations and more than 10 million people in the United States have AMD, according to the Foundation Fighting Blindness.

UA researchers are studying if the combination of dispensing asthma inhalers (corticosteroids) in the emergency department and supervising their use in elementary schools will increase the medication’s use among children with asthma and decrease emergency department visits.

UA engineers are using a $2.1 million grant to improve scanning technologies for challenging patient populations.

A cardiovascular research team at the University of Arizona Sarver Heart Center investigated in a lab model whether metformin, a common diabetes drug, could be an effective treatment for heart failure with preserved ejection fraction (HFpEF). The researchers found that the drug reduced left ventricular stiffness, thereby improving capacity for exercise. Metformin relaxes the left ventricle by making a heart muscle protein called titin more compliant.

Banner Health nurse navigators at the University of Arizona Cancer Center are paired with patients to guide them through their cancer journeys.

In pontocerebellar hypoplasia type 1b, two key biological structures are blocked from binding to one another — which ultimately stunts critical brain growth.

Two distinguished University of Arizona professors and innovators have been named as National Academy of Inventors Fellows. Thomas Koch, professor and dean of the College of Optical Sciences, and Harrison Barrett, Regents’ Professor of medical imaging, optical sciences and applied mathematics, will now join a growing cadre of distinguished fellows from the UA.

Family medicine physicians Ashley Krauser, DO, and Ana Mendez, MD, MPH, will provide a wide array of primary care services for patients of all ages across Tucson.

When a person is paralyzed by a stroke or an injury, the brain and the neuron networks that control movement become disconnected from the muscles. Dr. Andrew Fuglevand is using artificial intelligence to stimulate multiple muscles to elicit natural movement in ways previous methods have been unable to do.

UA Cancer Center opens clinical trial in Greater Phoenix for novel liver cancer treatment.